Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00026637 · ClinicalTrials.gov registry record · Phase 3
Depression and Health Outcomes in Refractory Epilepsy
A Phase 3 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 3
- Development phase
- 140
- Enrollment target
NCT00026637 is a Phase 3 study that has completed, run by Columbia University. The registered enrollment target is 140 participants.
The verdict
NCT00026637, a Phase 3 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 140 participants
- Enrollment target
Study Summary
To define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in persons with depression and refractory epilepsy.
Interventions
- DRUG sertraline
- BEHAVIORAL cognitive behavior therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2001-08 |
| Est. Completion | 2008-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00026637
The ClinicalTrials.gov registry entry for NCT00026637 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sertraline is the first listed.
NCT00026637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00026637 about?
NCT00026637 is a clinical study titled "Depression and Health Outcomes in Refractory Epilepsy". To define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in persons with depression and refractory epilepsy.
What is the current status of trial NCT00026637?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 2001-08. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00026637?
The interventions under investigation include: sertraline (DRUG), cognitive behavior therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00026637?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.